Evidence map›Paper›PMID 41354978›Full record

ArticleJournal of nanobiotechnology2025

Dual-pathway nanoengineering: spatiotemporal control of immunogenic apoptosis and macrophage phenotype reprogramming for augmented antitumor immunity.

Yunfeng Tang, Xiangtian Deng, Min Yi, Dong Wang, Cheng Zheng, Shichang Zhao, Renliang Zhao

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of nanobiotechnology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Yunfeng Tang *Head & Neck Oncology Ward, Cancer Center, West China Hospital, Cancer Center, Sichuan University, Chengdu, 610041, China.
Xiangtian Deng *Department of Orthopedics, Orthopedics Research Institute, West China Hospital, Sichuan University, Chengdu, 610041, China.
Min Yi *Department of Orthopedics, Orthopedics Research Institute, West China Hospital, Sichuan University, Chengdu, 610041, China.
Dong WangDepartment of Orthopedics, Orthopedics Research Institute, West China Hospital, Sichuan University, Chengdu, 610041, China.
Cheng ZhengNational Engineering Research Center for Biomaterials, Sichuan University, Chengdu, 610041, Sichuan, China. zhengcheng@scu.edu.cn.
Shichang Zhao *Department of Orthopedic Surgery, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, Shanghai Jiao Tong University, Shanghai, China. zhaoshichang0404@163.com.
Renliang Zhao *Department of Orthopedics, Orthopedics Research Institute, West China Hospital, Sichuan University, Chengdu, 610041, China. zrldcd@163.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Damage-associated molecular patterns (DAMPs) are released by cells through immunogenic cell death (ICD), reshaping the tumor microenvironment and demonstrating significant potential in cancer immunotherapy. We report a type of nanoparticle (FeS-IMQ-MnO

Indexed as

Antineoplastic AgentsApoptosisMacrophagesNanoparticlesNeoplasmsAnimalsCell Line, TumorGlutathioneHumansHyaluronan ReceptorsHyaluronic AcidImmunogenic Cell DeathImmunotherapyManganese CompoundsMiceOxidesAntineoplastic AgentsGlutathioneHyaluronan ReceptorsHyaluronic AcidManganese Compoundsmanganese dioxideOxidesReactive Oxygen SpeciesChemodynamic therapyImmunogenic cell deathLow-temperature photothermal therapy

Identifiers

PMID41354978
PMCPMC12797818

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.